ERS Genomics and GenScript Sign CRISPR/Cas9 License Agreement
License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research ERS Genomics Limited, which was formed to provide broad access to the...
Tag : genome sequencing
Skin Genomics Platform-driven DermTech to Present at Conference
DermTech, Inc. (NASDAQ: DMTK) (“DermTech”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today its management will present at the...
Gene Editing Company Metagenomi Presents New Findings
Metagenomi, a gene editing company, today presented data on their novel CRISPR-associated transposases (CAST) system that allows for precise integration of large DNA fragments into...
Genomic Vision Announces the Pursuit of Its Partnership With Sanofi
Genomic Vision(the “Company” – FR0011799907 – GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the...
Bluestar Genomics Closes $70M Series C Funding
Additional Funding and Scientific Expertise Advance Company’s Clinical Development and Efforts Towards Commercialization Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches...
Genome Screening Co. KSQ Therapeutics Appoints Chris Heberlig as CFO
KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune...
Verge Genomics Announces the Addition of Mario Saltarelli
Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine learning, announced today that Mario...
Taysha Gene Therapies Announces Publication of Preclinical Data
Preclinical data provide quantitative evidence of miRARE’s ability to exhibit genotype-dependent regulation of MECP2 gene expression across different brain regions in both wild type and...
Gene Therapy Company Gyroscope Therapeutics Postpones IPO
Gyroscope Therapeutics Holdings plc (“Gyroscope”), a clinical-stage gene therapy company focused on treating diseases of the eye, today announced it has postponed plans for its...
Vizgen Advances Spatial Genomics Research with New Program
Vizgen releases new dataset generated by Vizgen’s MERSCOPE™ which includes a high-resolution spatial map of GPCR and RTK expression within the mouse brain Vizgen, the life...